NEW YORK (GenomeWeb News) — CyBio and Promega plan to co-develop and co-market new high-throughput liquid-handling applications based on CyBio’s liquid-handling instruments, the company said today.
 
Under the agreement, CyBio and Promega will jointly develop and market validated application protocols for high-throughput screening processes in drug development and life science research.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.